A study evaluating safety and efficacy of Vismodegib for radiation induced multiple basal cell carcinomas of the scalp.
Phase of Trial: Phase IV
Latest Information Update: 07 Nov 2017
At a glance
- Drugs Vismodegib (Primary)
- Indications Basal cell cancer; Carcinoma
- Focus Adverse reactions; Therapeutic Use
- 07 Nov 2017 New trial record